In vivo profiling reveals immunomodulatory effects of sorafenib and dacarbazine on melanoma.
about
Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.Emerging growth factor receptor antagonists for the treatment of advanced melanoma.An exploratory study investigating the metabolic activity and local cytokine profile in patients with melanoma treated with pazopanib and paclitaxel.Immunomodulation in hepatocellular cancer.
P2860
In vivo profiling reveals immunomodulatory effects of sorafenib and dacarbazine on melanoma.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
In vivo profiling reveals immu ...... b and dacarbazine on melanoma.
@ast
In vivo profiling reveals immu ...... b and dacarbazine on melanoma.
@en
type
label
In vivo profiling reveals immu ...... b and dacarbazine on melanoma.
@ast
In vivo profiling reveals immu ...... b and dacarbazine on melanoma.
@en
prefLabel
In vivo profiling reveals immu ...... b and dacarbazine on melanoma.
@ast
In vivo profiling reveals immu ...... b and dacarbazine on melanoma.
@en
P2093
P2860
P1433
P1476
In vivo profiling reveals immu ...... b and dacarbazine on melanoma.
@en
P2093
Hans Steinert
Maria B Karpova
Marjam J Barysch
Michal J Okoniewski
Mirjana Urosevic-Maiwald
Reinhard Dummer
P2860
P304
P356
10.4161/2162402X.2014.988458
P50
P577
2015-01-07T00:00:00Z